TY - JOUR T1 - Neuroradiologic Phenotyping of Galactosemia: From the Neonatal Form to the Chronic Stage JF - American Journal of Neuroradiology JO - Am. J. Neuroradiol. DO - 10.3174/ajnr.A7016 AU - M.C. Rossi-Espagnet AU - S. Sudhakar AU - E. Fontana AU - D. Longo AU - J. Davison AU - A.L. Petengill AU - E. Bevivino AU - F.T. Pacheco AU - A.J. da Rocha AU - P. Hanagandi AU - M. Soldatelli AU - K. Mankad AU - L.L.F. do Amaral Y1 - 2021/01/21 UR - http://www.ajnr.org/content/early/2021/01/21/ajnr.A7016.abstract N2 - SUMMARY: Galactosemia is a rare genetic condition caused by mutation of enzymes involved in galactose and glucose metabolism. The varying clinical spectrum reflects the genetic complexity of this entity manifesting as acute neonatal toxicity syndrome, requiring prompt diagnosis and treatment, to more insidious clinical scenarios as observed in the subacute and chronic presentations. The current literature predominantly focuses on the long-standing sequelae of this disease. The purpose of this multicenter clinical report comprising 17 patients with galactosemia is to highlight the MR imaging patterns encompassing the whole spectrum of galactosemia, emphasizing the 3 main clinical subtypes: 1) acute neonatal presentation, with predominant white matter edema; 2) subacute clinical onset with a new finding called the “double cap sign”; and 3) a chronic phase of the disease with heterogeneous imaging findings. The knowledge of these different patterns together with MR spectroscopy and the clinical presentation may help in prioritizing galactosemia over other neonatal metabolic diseases and prevent possible complications. ER -